PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
CURE vs. UCO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

CURE vs. UCO

Last updated Jun 5, 2026

CURE (Direxion Daily Healthcare Bull 3x Shares) and UCO (ProShares Ultra Bloomberg Crude Oil) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while UCO is a Leveraged Commodities fund tracking the Dow Jones-UBS Crude Oil Sub-Index (200%). Both are passively managed. Over the past 10 years, CURE returned 12.46%/yr vs -11.98%/yr for UCO. At a 0.12 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 0.95%/yr for UCO.

Performance

CURE vs. UCO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares Ultra Bloomberg Crude Oil (UCO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CURE achieves a -10.92% return, which is significantly lower than UCO's 139.34% return. Over the past 10 years, CURE has outperformed UCO with an annualized return of 12.46%, while UCO has yielded a comparatively lower -11.98% annualized return.

CURE

1D
9.14%
1M
12.73%
YTD
-10.92%
6M
-9.12%
1Y
31.64%
3Y*
2.38%
5Y*
1.98%
10Y*
12.46%

UCO

1D
-3.93%
1M
-5.57%
YTD
139.34%
6M
124.58%
1Y
115.57%
3Y*
24.38%
5Y*
21.18%
10Y*
-11.98%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. UCO - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares		-10.92%22.55%-8.47%-9.40%-20.51%88.30%5.02%55.66%2.82%69.32%
UCO
ProShares Ultra Bloomberg Crude Oil		139.34%-29.75%5.36%-13.89%39.71%139.26%-92.91%53.83%-43.26%0.34%

Correlation

The correlation between CURE and UCO is -0.32, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.32

Correlation (3Y)
Calculated over the trailing 3-year period

-0.18

Correlation (5Y)
Calculated over the trailing 5-year period

-0.05

Correlation (10Y)
Calculated over the trailing 10-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Jun 16, 2011

0.12

The correlation between CURE and UCO shifts across timeframes, from -0.32 (1 year) to 0.12 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Direxion Daily Healthcare Bull 3x Shares

ProShares Ultra Bloomberg Crude Oil

Often compared with CURE:
CURE vs. XLVCURE vs. RXLCURE vs. PILLCURE vs. UTSLCURE vs. CNRGCURE vs. CWEBCURE vs. RETL
Often compared with UCO:
UCO vs. USOUCO vs. SCOUCO vs. OILUUCO vs. BOILUCO vs. ERXUCO vs. LABUUCO vs. OIH

Return for Risk

CURE vs. UCO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
CURE
CURE Risk / Return Rank: 2323
Overall Rank
CURE Sharpe Ratio Rank: 2222
Sharpe Ratio Rank
CURE Sortino Ratio Rank: 2525
Sortino Ratio Rank
CURE Omega Ratio Rank: 2323
Omega Ratio Rank
CURE Calmar Ratio Rank: 2323
Calmar Ratio Rank
CURE Martin Ratio Rank: 2121
Martin Ratio Rank
UCO
UCO Risk / Return Rank: 5454
Overall Rank
UCO Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
UCO Sortino Ratio Rank: 5050
Sortino Ratio Rank
UCO Omega Ratio Rank: 5151
Omega Ratio Rank
UCO Calmar Ratio Rank: 6868
Calmar Ratio Rank
UCO Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. UCO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and ProShares Ultra Bloomberg Crude Oil (UCO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

CUREUCODifference
Sharpe ratioReturn per unit of total volatility
0.72
2.03

-1.31

Sortino ratioReturn per unit of downside risk
1.33
2.39

-1.06

Omega ratioGain probability vs. loss probability

1.15

1.31

-0.16

Calmar ratioReturn relative to maximum drawdown

1.02

3.34

-2.32

Martin ratioReturn relative to average drawdown

2.35

6.32

-3.97

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CURE vs. UCO - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.72, which is lower than the UCO Sharpe Ratio of 2.03. The chart below compares the historical Sharpe Ratios of CURE and UCO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Sharpe Ratios by Period

CUREUCODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.72

2.03

-1.31

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.05

0.36

-0.31

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.25

-0.17

+0.42

Sharpe Ratio (All Time)

Calculated using the full available price history

0.47

-0.34

+0.82

Drawdowns

CURE vs. UCO - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum UCO drawdown of -99.95%. Use the drawdown chart below to compare losses from any high point for CURE and UCO.

Loading charts...

Drawdown Indicators

CUREUCODifference

Max Drawdown

Largest peak-to-trough decline

-69.19%

-99.95%

+30.76%

Max Drawdown (1Y)

Largest decline over 1 year

-31.10%

-34.77%

+3.67%

Max Drawdown (3Y)

Largest decline over 3 years

-51.93%

-50.38%

-1.55%

Max Drawdown (5Y)

Largest decline over 5 years

-52.23%

-67.24%

+15.01%

Max Drawdown (10Y)

Largest decline over 10 years

-69.19%

-98.75%

+29.56%

Current Drawdown

Current decline from peak

-29.29%

-99.26%

+69.97%

Average Drawdown

Average peak-to-trough decline

-18.15%

-85.49%

+67.34%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.48%

18.34%

-4.86%

Volatility

CURE vs. UCO - Volatility Comparison

The current volatility for Direxion Daily Healthcare Bull 3x Shares (CURE) is 14.72%, while ProShares Ultra Bloomberg Crude Oil (UCO) has a volatility of 20.99%. This indicates that CURE experiences smaller price fluctuations and is considered to be less risky than UCO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

CUREUCODifference

Volatility (1M)

Calculated over the trailing 1-month period

14.72%

20.99%

-6.27%

Volatility (6M)

Calculated over the trailing 6-month period

31.07%

46.57%

-15.50%

Volatility (1Y)

Calculated over the trailing 1-year period

44.12%

57.26%

-13.14%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

43.88%

59.81%

-15.93%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.58%

71.35%

-21.77%

CURE vs. UCO - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than UCO's 0.95% expense ratio.

Dividends

CURE vs. UCO - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.20%, while UCO has not paid dividends to shareholders.

PositionTTM202520242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares		1.20%1.12%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%
UCO
ProShares Ultra Bloomberg Crude Oil		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions

CURE and UCO have a correlation of -0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

UCO has higher volatility (20.99%) compared to CURE (14.72%). In terms of maximum drawdown, CURE dropped -69.19% vs UCO's -99.95%.

On 10-year performance, CURE leads with 12.46% vs -11.98% for UCO. On fees, UCO is cheaper at 0.95% per year. On volatility, CURE has been the lower-risk option at 14.72%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, CURE has performed better with a 12.46% return vs -11.98%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

UCO is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.

CURE has the higher dividend yield at 1.20%, compared with 0.00% for UCO.

CURE is categorized as Leveraged Equities, while UCO is Leveraged Commodities. CURE tracks Health Care Select Sector Index (300%), while UCO tracks Dow Jones-UBS Crude Oil Sub-Index (200%). They also come from different issuers: Direxion and ProShares. Their fees differ too: 1.08% for CURE and 0.95% for UCO.

UCO currently has the higher Sharpe Ratio (2.03 vs 0.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CURE and UCO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer